Wells Fargo & Company Charles River Laboratories International, Inc. Transaction History

Wells Fargo & Company

$407 Billion
Q2 2024

A detailed history of Wells Fargo & Company transactions in Charles River Laboratories International, Inc. stock. As of the latest transaction made, Wells Fargo & Company holds 561,122 shares of CRL stock, worth $111 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares

561,122

Previous 569,415 1.46%

Holding current value

$111 Million

Previous $154 Million 24.87%

% of portfolio

0.03%

Previous 0.04%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	SELL	$206.39 - $268.73 $1.71 Million - $2.23 Million	-8,293 Reduced 1.46%	561,122 $116 Million
Q1 2024 May 10, 2024	BUY	$203.52 - $273.43 $4.86 Million - $6.53 Million	23,890 Added 4.38%	569,415 $154 Million
Q4 2023 Feb 09, 2024	SELL	$164.52 - $238.84 $4.48 Million - $6.5 Million	-27,223 Reduced 4.75%	545,525 $129 Million
Q3 2023 Nov 13, 2023	BUY	$194.44 - $217.61 $5.52 Million - $6.18 Million	28,413 Added 5.22%	572,748 $112 Million
Q2 2023 Aug 15, 2023	BUY	$183.71 - $210.25 $6.19 Million - $7.09 Million	33,721 Added 6.6%	544,335 $114 Million
Q1 2023 May 12, 2023	BUY	$191.89 - $259.92 $8.26 Million - $11.2 Million	43,065 Added 9.21%	510,614 $103 Million
Q4 2022 Feb 13, 2023	SELL	$197.11 - $250.07 $3.38 Million - $4.29 Million	-17,165 Reduced 3.54%	467,549 $102 Million
Q3 2022 Nov 14, 2022	BUY	$182.44 - $250.54 $3.8 Million - $5.22 Million	20,835 Added 4.49%	484,714 $95.4 Million
Q2 2022 Aug 12, 2022	SELL	$204.13 - $302.4 $4.99 Million - $7.4 Million	-24,465 Reduced 5.01%	463,879 $99.3 Million
Q1 2022 May 16, 2022	BUY	$255.51 - $362.11 $37 Million - $52.4 Million	144,662 Added 42.09%	488,344 $139 Million
Q4 2021 Feb 14, 2022	BUY	$351.38 - $448.68 $11.6 Million - $14.9 Million	33,138 Added 10.67%	343,682 $129 Million
Q3 2021 Nov 15, 2021	SELL	$372.64 - $458.3 $5.14 Million - $6.32 Million	-13,792 Reduced 4.25%	310,544 $128 Million
Q2 2021 Aug 16, 2021	SELL	$294.17 - $371.65 $20.8 Million - $26.3 Million	-70,764 Reduced 17.91%	324,336 $120 Million
Q1 2021 May 13, 2021	SELL	$249.67 - $299.48 $31.6 Million - $37.9 Million	-126,475 Reduced 24.25%	395,100 $115 Million
Q4 2020 Feb 09, 2021	SELL	$222.0 - $252.62 $109 Million - $124 Million	-492,006 Reduced 48.54%	521,575 $130 Million
Q3 2020 Nov 05, 2020	SELL	$175.56 - $226.45 $32.4 Million - $41.7 Million	-184,329 Reduced 15.39%	1,013,581 $230 Million
Q2 2020 Aug 13, 2020	BUY	$118.84 - $189.72 $7.4 Million - $11.8 Million	62,244 Added 5.48%	1,197,910 $209 Million
Q1 2020 May 14, 2020	BUY	$98.9 - $178.34 $112 Million - $203 Million	1,135,666 New	1,135,666 $143 Million

Others Institutions Holding CRL

# of Institutions

732

Shares Held

51.8M

Call Options Held

233K

Put Options Held

236K

View Full List

About CHARLES RIVER LABORATORIES INTERNATIONAL, INC.

Ticker CRL
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 50,863,300
Market Cap $10B
Description
Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...

More about CRL

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Wells Fargo & Company, based on Form 13F filings with the SEC.

News

Stay updated on Wells Fargo & Company with notifications on news.

Account

Wells Fargo & Company Charles River Laboratories International, Inc. Transaction History